Nexus Pharmaceuticals Receives Patent for EMERPHED®

Nexus Pharmaceuticals Receives Patent for EMERPHED®

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED® Ready-To-Use Ephedrine Sulfate Injection, the first...